Abstract
We previously demonstrated that insulin-induced severe hypoglycemia-associated sudden death is largely mediated by fatal cardiac arrhythmias. In the current study, a pharmacological approach was taken to explore the potential contribution of hypoglycemic seizures and the sympathoadrenergic system in mediating severe hypoglycemia-associated sudden death. Adult Sprague-Dawley rats were randomized into one of four treatment groups: 1) saline (SAL), 2) anti-arrhythmic (β1 blocker atenolol), 3) antiseizure (levetiracetam), and 4) combination antiarrhythmic and antiseizure (β1 Blocker+Levetiracetam). All rats underwent hyperinsulinemic severe hypoglycemic clamps for 3.5 h. When administered individually during severe hypoglycemia, β1 blocker reduced 2nd and 3rd degree heart block by 7.7- and 1.6-fold, respectively, and levetiracetam reduced seizures 2.7-fold, but mortality in these groups did not decrease. However, it was combined treatment with both β1 blocker and levetiracetam that remarkably reduced seizures and completely prevented respiratory arrest, while also eliminating 2nd and 3rd degree heart block, leading to 100% survival. These novel findings demonstrate that, in mediating sudden death, hypoglycemia elicits two distinct ...Continue Reading
References
Mar 3, 1979·Lancet·I LagerU Smith
Oct 1, 1992·The American Journal of Physiology·C H Lang
Sep 1, 1991·Diabetes·I B HirschP E Cryer
Jan 1, 1991·Diabetic Medicine : a Journal of the British Diabetic Association·R B Tattersall, G V Gill
Jun 1, 1990·British Journal of Clinical Pharmacology·D KerrR B Tattersall
Jul 1, 1985·Naunyn-Schmiedeberg's Archives of Pharmacology·B LemmerM Fink
Oct 1, 1983·Diabetes·P De FeoP Brunetti
Aug 1, 1981·European Journal of Clinical Investigation·R J CorrallE B French
Jun 1, 1996·Developmental Medicine and Child Neurology·J HewertsonD P Southall
Nov 1, 1996·The American Journal of Physiology·M ZhaoK H Muntz
May 10, 2000·Epilepsia·A S BlumD L Schomer
Sep 22, 2000·Epilepsia·S D ShorvonP Loiseau
Jun 19, 2001·Neuroscience Letters·I NiespodzianyD G Margineanu
Nov 21, 2001·Pharmacotherapy·C A Hovinga
Jun 28, 2002·British Journal of Pharmacology·J-M RigoH Klitgaard
Apr 30, 2003·Diabetes·Salomon Banarer, Philip E Cryer
May 27, 2003·Diabetes·Robert T C E RobinsonSimon R Heller
Jun 24, 2004·Proceedings of the National Academy of Sciences of the United States of America·Berkley A LynchBruno Fuks
Dec 21, 2005·Diabetologia·T SkrivarhaugG Joner
Mar 25, 2006·European Journal of Pharmacology·Michel GillardBruno Fuks
May 10, 2007·Cell Metabolism·Qingchun TongBradford B Lowell
Mar 18, 2008·Clinical Therapeutics·Réginald HulhovenArmel Stockis
Apr 1, 2008·Diabetes·Owen ChanRobert S Sherwin
Nov 27, 2008·Diabetes·Philip E Cryer
Oct 17, 2009·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·Robert J TanenbergAlmond J Drake
Dec 23, 2009·Neuropharmacology·Yi ZhengAndrew J Cole
Jan 21, 2010·Diabetes·Erwin C PuenteSimon J Fisher
Apr 18, 2013·American Journal of Physiology. Endocrinology and Metabolism·Candace M RenoSimon J Fisher
Jul 10, 2013·Diabetes·Candace M RenoSimon J Fisher
Jan 5, 2014·PloS One·Margaret MaheandiranPeter L Carlen
Mar 13, 2014·JAMA Internal Medicine·Andrew I GellerDaniel S Budnitz
Feb 1, 2017·Diabetes·Elaine ChowSimon R Heller
Sep 10, 2017·Diabetes·Candace M RenoSimon J Fisher
Citations
Aug 9, 2019·PloS One·Deepak Kana KadayakkaraGregory Buller
Dec 24, 2019·Cardiology in Review·Aaqib H MalikHoward A Cooper
Aug 24, 2019·Diabetes·Candace M RenoSimon J Fisher
Apr 27, 2019·Frontiers in Physiology·Hao-Ran DingXiao-Lei Shi
Nov 7, 2019·Current Diabetes Reviews·Ronald B Brown
Jul 30, 2021·Journal of Medical Case Reports·Temesgen Tilahun, Guteta Gudina
Jun 22, 2020·Seizure : the Journal of the British Epilepsy Association·Kensuke NakamuraHideo Yasunaga
Sep 12, 2020·Current Pharmaceutical Design·Niki KatsikiDimitri P Mikhailidis
Jun 24, 2021·Neurology·Brandon B HolmesDawn Gano
Oct 11, 2021·Nephrology·Israel KhanimovEyal Leibovitz